Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017407
Filing Date
2025-06-16
Accepted
2025-06-16 16:52:43
Documents
2
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 form4-06162025_080639.html 4  
1 form4-06162025_080639.xml 4 4319
2 ex24-06162025_080639.htm EX-24 7088
  Complete submission text file 0001415889-25-017407.txt   13173
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Issuer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 88 KEARNY STREET, SUITE 1800 SAN FRANCISCO CA 94108
Business Address
Dalal Anupam (Reporting) CIK: 0001602474 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 251050845